Madrigal Pharmaceuticals, Inc. (MDGL): Net Income
-$288.28M
Year ended 2025-12-31
-$325.10M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$288.28M | n/m | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | -$465.89M | n/m | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | -$373.63M | n/m | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | -$295.35M | n/m | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | -$241.85M | n/m | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | -$202.24M | n/m | 2023-03-03, From 2020-01-01 |
| 2019-12-31 | -$83.95M | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | -$32.81M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$31.15M | n/m | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | -$26.39M | n/a | 2019-02-27, From 2016-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$288.28M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | -$381.39M | n/m |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $78.34M | n/m |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $158.69M | +9.1% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $391.00M | +72.7% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $190.30M | -11.3% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $30.11M | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $62.87M | -9.1% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $99.65M | -29.4% |
Compare MDGL, IONS, ANIP, HRMY side by side · Screen every company in Pharmaceutical Preparations ↗